LAB21, Inc., New York, has launched a new anti-aging anti-acne therapy
November 15, 2005
LAB21, Inc., New York, has launched a new anti-aging anti-acne therapy for adults based on patent-pending DNA technology. The cream prevents new blemishes from coming to the surface, helps current blemishes heal and reduces the scarring and marks caused by previous breakouts due to individual DNA analysis. LAB21 is offering licenses to pharmaceutical and biotechnology companies.